Patten Group, Inc. Astrazeneca PLC Transaction History

Patten Group, Inc.

$426 Million
Q1 2025

A detailed history of Patten Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Patten Group, Inc. holds 51,985 shares of AZN stock, worth $3.68 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

51,985

Previous 51,293 1.35%

Holding current value

$3.68 Million

Previous $3.36 Million 13.69%

% of portfolio

0.9%

Previous 0.76%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $45,236 - $53,948	692 Added 1.35%	51,985 $3.82 Million
Q4 2024 Feb 06, 2025	SELL	$63.2 - $79.58 $99,476 - $125,258	-1,574 Reduced 2.98%	51,293 $3.36 Million
Q3 2024 Oct 08, 2024	SELL	$76.67 - $87.62 $40,251 - $46,000	-525 Reduced 0.98%	52,867 $4.12 Million
Q2 2024 Jul 25, 2024	BUY	$66.81 - $80.83 $8,084 - $9,780	121 Added 0.23%	53,392 $4.16 Million
Q1 2024 Apr 17, 2024	SELL	$61.03 - $69.57 $23,557 - $26,854	-386 Reduced 0.72%	53,271 $3.61 Million
Q4 2023 Jan 10, 2024	SELL	$61.89 - $69.28 $55,329 - $61,936	-894 Reduced 1.64%	53,657 $3.61 Million
Q3 2023 Oct 12, 2023	SELL	$64.85 - $71.7 $35,278 - $39,004	-544 Reduced 0.99%	54,551 $3.69 Million
Q2 2023 Jul 26, 2023	SELL	$69.91 - $75.81 $11,395 - $12,357	-163 Reduced 0.29%	55,095 $3.94 Million
Q1 2023 Apr 06, 2023	SELL	$63.15 - $71.6 $189 - $214	-3 Reduced 0.01%	55,258 $3.84 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $63,913 - $83,048	-1,179 Reduced 2.09%	55,261 $3.75 Million
Q3 2022 Oct 13, 2022	BUY	$53.02 - $135.75 $18,079 - $46,290	341 Added 0.61%	56,440 $3.13 Million
Q2 2022 Jul 18, 2022	BUY	$59.26 - $71.14 $137,779 - $165,400	2,325 Added 4.32%	56,099 $3.75 Million
Q1 2022 Apr 28, 2022	SELL	$55.72 - $67.12 $123,977 - $149,342	-2,225 Reduced 3.97%	53,774 $3.57 Million
Q4 2021 Jan 20, 2022	SELL	$54.02 - $63.83 $108 - $127	-2 Reduced -0.0%	55,999 $3.26 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $7,833 - $8,571	-141 Reduced 0.25%	56,001 $3.36 Million
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $64,640 - $80,340	-1,335 Reduced 2.32%	56,142 $3.36 Million
Q1 2021 Apr 23, 2021	SELL	$47.16 - $54.44 $69,843 - $80,625	-1,481 Reduced 2.51%	57,477 $2.86 Million
Q4 2020 Feb 02, 2021	BUY	$48.52 - $58.02 $3,153 - $3,771	65 Added 0.11%	58,958 $2.95 Million
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $8,968 - $10,325	169 Added 0.29%	58,893 $3.23 Million
Q2 2020 Jul 20, 2020	SELL	$43.1 - $55.31 $48,056 - $61,670	-1,115 Reduced 1.86%	58,724 $3.11 Million
Q1 2020 Apr 16, 2020	SELL	$37.79 - $51.33 $224,472 - $304,900	-5,940 Reduced 9.03%	59,839 $2.67 Million
Q4 2019 Jan 14, 2020	BUY	$42.46 - $50.46 $61,354 - $72,914	1,445 Added 2.25%	65,779 $3.28 Million
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $78,755 - $89,257	1,963 Added 3.15%	64,334 $2.87 Million
Q2 2019 Jul 11, 2019	BUY	$37.28 - $41.68 $164,814 - $184,267	4,421 Added 7.63%	62,371 $2.58 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $1.51 Million - $1.83 Million	42,649 Added 278.73%	57,950 $2.34 Million
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $200,702 - $225,913	5,445 Added 55.25%	15,301 $581,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $3,997 - $4,567	115 Added 1.18%	9,856 $390,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $300,274 - $322,001	8,691 Added 827.71%	9,741 $342,000
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $10,814 - $12,014	-328 Reduced 23.8%	1,050 $37,000
Q3 2017 Dec 13, 2017	BUY	$28.96 - $34.0 $28,236 - $33,150	975 Added 241.94%	1,378 $47,000
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $28,236 - $33,150	-975 Reduced 70.75%	403 $47,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,378	1,378 $42,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account